Cambridge Healthtech Institute’s Sixteenth Annual
Engineering Antibodies
New Science and Technologies for the Selection, Engineering and Targeting of the Next Generation of Antibody Therapeutics
Part of the 11th Annual PEGS: the essential protein engineering summit
May 6-7, 2015 | World Trade Center | Boston, Massachusetts


The field of protein engineering is at an exciting point in its development, with new generations of therapeutic antibodies now reaching the market, great advances in protein science and a body of clinical evidence that can be used to inform the development of safe, highly effective therapies for unmet medical needs. At PEGS, Engineering Antibodies presents the state of the art in technologies used by protein engineers working at the discovery and design stage to quickly and efficiently craft biotherapeutics directed at the most elusive targets and biological functions. Emphasis will be given to new presentations that highlight unpublished work in this important field.

Topics will include, but are not limited to: 

  • Antibody activation by environmental triggers
  • Antibody discovery for emerging targets and indications
  • Characterization and exploitation of natural immune responses
  • Computational tools in antibody research
  • Engineering protein interaction hotspots
  • Measurement and control of non-specific antibody binding
  • New research technologies for protein engineering
  • Product differentiation for antibody therapeutics
  • Protein engineering to support the generation of quality binders
  • Single cell sequencing in antibody discovery
  • Target discovery for rare antibodies
  • Using NGS to interrogate transgenic species repertoires

Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.

Deadline for submission is October 3, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Kent Simmons
Program Director
Cambridge Healthtech Institute
Phone: 207-869-9199
E-mail: ksimmons@healthtech.com 

For partnering and sponsorship information, please contact:
Jason Gerardi (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5452
E: jgerardi@healthtech.com 

Carol Dinerstein (Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: 781.972.5471
E: dinerstein@healthtech.com